#rgen

  1. Analyst Ratings For Repligen

    By Benzinga Insights In the last three months, 6 analysts have published ratings on Repligen (NASDAQ: RGEN ), offering a diverse range of perspectives from bullish to bearish. The following table encapsulates their recent ratings, offering a glimpse into the evolving sentiments over
  2. Arista Networks, JinkoSolar, Repligen, Shutterstock And Other Big Stocks Moving Higher On Tuesday

    By Lisa Levin U.S. stocks traded lower, with the Dow Jones falling more than 50 points on Tuesday. Here are some major stocks recording gains in today’s session . Verve Therapeutics, Inc. (NASDAQ: VERV ) gained 27% to $11.95. Eli Lilly said it will acquire rights under Beam Therapeut
  3. Earnings Scheduled For October 31, 2023

    By Benzinga Insights Companies Reporting Before The Bell • BBVA (NYSE: BBVA ) is likely to report earnings for its third quarter. • BP (NYSE: BP ) is expected to report quarterly earnings at $1.37 per share on revenue of $57.71 billion. • Anheuser-Busch InBev (NYSE: BUD ) is likely to repo
  4. Humana, Waters, e.l.f. Beauty, Teva Pharmaceutical And Other Big Stocks Moving Higher On Wednesday

    By Lisa Levin U.S. stocks traded lower, with the Dow Jones falling around 200 points on Wednesday. Here are some big stocks recording gains in today’s session. Powell Industries, Inc. (NASDAQ: POWL ) shares jumped 36.3% to $83.52 following upbeat quarterly results. Vertiv Holdings Co
  5. Top 5 Health Care Stocks That May Collapse In July

    By Lisa Levin The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down. When compa